Formative research to shape HPV vaccine introduction strategies in Peru

Salud Publica de Mexico

Volumn 52, Issue 3, 2010, Pages 226-233

  Bartolini, Rosario M ^a   Drake, Jennifer Kidwell ^b   Creed Kanashiro, Hilary M ^a   Díaz Otoya, Margarita M ^a   Mosqueira Lovón, Nelly Rocío ^a   Penny, Mary E ^a,c   Winkler, Jennifer L ^b   LaMontagne, D Scott ^b   Bingham, Allison ^b  

^a INSTITUTO DE INVESTIGACIÓN NUTRICIONAL   (Peru)

^b PATH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cervical cancer; Human papillomavirus (HPV) vaccine; Peru; Qualitative research

Indexed keywords

EID: 77955496662     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.1590/S0036-36342010000300007     Document Type: Article

References (37)

1. Parkin DM, Almonte M, Bruni L, Clifford C, Curado M, Pineros M. Burden and trends of type-specific human papillomavirus infections and related diseases in the Latin America and Caribbean region. Vaccine 2008;26(Suppl 11):L1-L15.
2. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347(21):1645-1651.
3. Ling M, Kanayama M, Roden R, Wu TC. Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers. J Biomed Sci 2000;7(5):341-356.
4. Hildesheim A, Markowitz L, Avila MH, Franceschi S. Research needs following initial licensure of virus-like particle HPV vaccines. Vaccine 2006;24(Suppl 3):227-232.
5. Burchell AN, Winer RL, de Sanjose S, Franco EL. Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006;24(Suppl 3):52-61.
6. Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL. HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 2006;24(Suppl 3):26-34.
7. World Health Organization (WHO), Department of Immunization, Vaccines and Biologicals. Vaccine Introduction Guidelines: Adding a Vaccine to a National Immunization Programme: Decision and Implementation. Geneva (Switzerland): WHO, 2005.
8. Pan American Health Organization (PAHO). Regional Strategy and Plan of Action for Cervical Cancer Prevention and Control. Washington (DC): PAHO, 2008.
9. Correa P. The war against cervical cancer in Latin America and the Caribbean. Triumph of the scientists. Challenge for the community. Vaccine 2008;26(Suppl 11):iii-iv.
10. Newes G, Helitzer DL, Caulfield LE, Borwn KH. Theory and practice: applying the ecological model to formative research for a WIC training program in New York State. Health Educ Res 2000;15(3):283-291.
11. Wittet S. Cervical cancer vaccine project [fact sheet]. Seattle (WA): PATH, 2006.
12. Bingham A, Janmohamed A, Bartolini R, Creed-Kanashiro H, Katahoire A, Khan I, et al. An approach to formative research in HPV vaccine introduction planning in low-resource settings. The Open Vaccine Journal 2009;2:1-16.
13. Green LM, Kreuter MW. Health Promotion Planning: An Educational and Ecological Approach. 3rd ed. Mountain View (CA): Mayfield, 1999.
14. Kuzel AJ. Sampling in qualitative inquiry. In Crabtree BF, Miller WL, eds. Doing Qualitative Research. Newbury Park, CA: Sage Publications, 1992: 33-46.
15. PATH, Instituto de Investigación Nutricional (IIN). Shaping a Strategy to Introduce HPV Vaccines in Peru: Formative Research Results from the HPV Vaccines: Evidence For Impact Project. Seattle (WA): PATH, 2009.
16. Miles MB, Huberman AM. Qualitative Data Analysis: An Expanded Sourcebook. Thousand Oaks (CA): Sage Publications, 1994.
17. Gilchrist VJ. Key informant interviews. In Crabtree BF, Miller WL, eds. Doing Qualitative Research. Newbury Park, CA: Sage Publications, 1992: 70-89.
18. Creed-Kanashiro HM, Bartolini RM, Fukumoto MN, Uribe TG, Robert RC, Bentley ME. Formative research to develop a nutrition education intervention to improve dietary iron intake among women and adolescent girls through community kitchens in Lima, Peru. J Nutr 2003;133(11 Suppl 2):3987S-3991S.
19. World Health Organization (WHO). Training for Mid-Level Managers: Cold Chain, Vaccines and Safe-Injection Equipment Management. Geneva (Switzerland): WHO, 2008.
20. United States Agency for International Development (USAID). Immunization Essentials: A Practical Field Guide. Washington (DC): USAID, 2003.
21. Biellik R, Levin C, Mugisha E, LaMontagne DS, Bingham A, Kaipilyawar S, et al. Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings. Vaccine 2009;27(44):6203-6209.
22. Andrus JK, Lewis MJ, Goldie SJ, García PJ, Winkler JL, Ruiz-Matus C, et al. Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean. Vaccine 2008;26(Suppl 11):L80-L87.
23. Winkler JL, Wittet S, Bartolini RM, Creed-Kanashiro HM, Lazcano-Ponce E, Lewis-Bell K, et al. Determinants of human papillomavirus vaccine acceptability in Latin America and the Caribbean. Vaccine 2008;26(Suppl 11):L73-L79.
24. World Health Organization (WHO), United Nations Population Fund. Preparing for the Introduction of HPV Vaccines: Policy and Programme Guidance for Countries. Geneva (Switzerland): WHO, 2006.
25. Instituto Nacional de Estadística e Informática (INEI). Compendio Estadístico 2006. Lima (Peru): INEI, 2006.
26. Kaljee LM, Pack R, Pach A, Nyamete A, Stanton BF. Sociobehavioural research methods for the introduction of vaccines in the Diseases of the Most Impoverished Programme. J Health Popul Nutr 2004;22(3):293-303.
27. Jheeta M, Jewell J. Childhood vaccination in Africa and Asia: the effects of parents' knowledge and attitudes. Bull World Health Organ 2008;86(6):419.
28. Garcia SG, Becker D, Tatum C, Aldrich T, Fernandez CA. Linking cervical cancer to the human papillomavairus: findings from a qualitative study with Mexican women. Health Care Women Int 2007;28(2):192-205.
29. Moreira Jr. ED, Oliveira BG, Ferraz FM, Costa S, Costa Filho JO, Karic G. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil; implications for health education and prevention. Int J Gynecol Cancer 2006;16(2):599-603.
30. Agurto I, Bishop A, Sánchez G, Betancourt Z, Robles S. Perceived barriers and benefits to cervical cancer screening in Latin America. Prev Med 2004;39(1):91-98.
31. Bingham A, Bishop A, Coffey P, Winkler J, Bradley J, Dzuba I, et al. Factors affecting utilization of cervical cancer prevention services in low-resource settings. Salud Publica Mex 2003;45(Suppl 3):S408-S416.
32. Pan American Health Organization (PAHO). Youth: Choices and Change; Promoting Health Behaviors in Adolescents. Washington (DC): PAHO, 2005.
33. Zimet GD, Liddon N, Rosenthal SL, Lazcano-Ponce E, Allen B. Chapter 24: Psychosocial aspects of vaccine acceptability. Vaccine 2006;24(Suppl 3):201-209.
34. Kahn JA, Burk RD. Papillomavirus vaccines in perspective. The Lancet 2007;369(9580):2135-2137.
35. Mays RM, Sturm LM, Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med 2004;58(7):1405-1413.
36. Almonte M, Albero G, Molano M, Carcamo C, Garcia PJ, Perez GI. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine 2008;26(Suppl 11):L16-L36.
37. Luciani S, Andrus JK. A Pan American Health Organization strategy for cervical cancer prevention and control in Latin America and the Caribbean. Reprod Health Matters 2008;16(32):59-66.